Ocean View, Delaware, July 05, 2016 (GLOBE NEWSWIRE) -- Global Assisted Reproductive Technology Market size is expected to reach USD 31.4 billion by 2023; as per a new research report by Global Market Insights, Inc. Key driving factors include increasing prevalence of infertility owing to increase sedentary lifestyle, obesity, and stress.
Frozen nondonor procedures accounted for USD 4.9 billion in 2015, and is expected to exhibit a significant growth up to 2023. As reported by U.S. CDC in 2012, 97% women younger than age 35 used their own eggs (nondonor) while about 3% of women used donor eggs. Delayed parenthood decisions and increased patient awareness about advanced contraceptives and adoption of ART services expected to boost assisted reproductive technology market.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/506
According to WHO, one in every four couples in developing countries have been found to be infertile and overall infertility prevalence in women has remained similar from 1990 to 2010. As reported by U.S. CDC, infertility prevalence rate is 10.9% in 2010. ART industry is also projected to witness substantial growth due to cultural shift of infertile patients towards advanced procedures such as IVF, ICSI, GIFT, ZIFT.
As per the Society of Human Reproduction and Embryology, Europe assisted reproductive technology market size is approximately 55% of all reported ART cycles. Over 600,000 cycles were reported from 33 EU countries in 2014. Regulatory trends, particularly in Europe and the U.S. will play a critical role in industry evolution and penetration.
U.S. assisted reproductive technology market share accounted for 95% of total North America revenue in 2015. Advanced healthcare facilities in and education among the patients enables propel demand.
Browse key industry insights spread across 73 pages with 33 market data tables & 30 figures & charts from the report, “Assisted Reproductive Technology (ART) Market Size by Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Egg/Embryo bank), Industry Analysis Report, Regional Outlook (U.S, Canada, UK, France, Germany, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/assisted-reproductive-technology-market
Key insights from the report include:
- Global assisted reproductive technology market size generated revenue of USD 22.3 billion in 2015.
- North America is driven by favorable reimbursement policies on advanced ART procedures and high infertility prevalence.
- Asia Pacific is expected to witness lucrative growth over the forecast period due to increase in disposable income, increase in the health care infrastructure. APAC is led by Japan, China, India. Japan assisted reproductive technology market, accounting for more than 45% of sales revenue in 2015.
- Increasing infertility prevalence is a key driver for Europe, led by UK, Germany, France, Italy and Spain. Germany reproductive technology market size was responsible for over 28% of regional sales in 2015, with more than 5% growth anticipated by 2023.
- Brazil reproductive technology market share was USD 0.62 billion in 2015, which is set to continue being the fastest growing industry in LATAM.
- Key industry players include Irvine Scientific, Origio a/s, Vitro Life, Esco Micro Pte. Ltd., IVFtech ApS, Cook Medical, Research Instruments, Genea Limited, Smiths Medical, Thermo Fisher Scientific, Inc. etc.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/506
Global Market Insights has segmented the assisted reproductive technology (ART) industry on the basis of procedure, and region:
- Assisted Reproductive Technology Procedure Analysis (Revenue, USD Million, 2012 - 2023)
- Fresh Donor
- Fresh Nondonor
- Frozen Donor
- Frozen Nondonor
- Egg/Embryo bank
- Assisted Reproductive Technology Regional Analysis (Revenue, USD Million, 2012 - 2023)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- India
- China
- Japan
- Latin America
- North America
- Brazil
- Mexico
- MEA
- South Africa
Browse Related Reports:
- Contraceptives Market Size By Product (Drugs [Oral Contraceptive Pills, Injectables, Topical], By Devices Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal Implants, Copper IUD, Hormonal IUD], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Japan, China, India, Brazil, South Africa), Application Potential, Price Trend, Competitive Market Share & Forecast, 2016 - 2023
https://www.gminsights.com/industry-analysis/contraceptives-market
- HIV Diagnostics Market Size By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
https://www.gminsights.com/industry-analysis/hiv-diagnostics-market
Read our insightful industry blogs
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.